UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers

Retrovirology, 2018-09, Vol.15 (1), p.61-61, Article 61

2018

Volltextzugriff (PDF)

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody

PLoS pathogens, 2019-12, Vol.15 (12), p.e1008064

2019

Volltextzugriff (PDF)

Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes

PLoS pathogens, 2013-10, Vol.9 (10), p.e1003738-e1003738

2013

Volltextzugriff (PDF)

The Neutralizing Antibody Response to the HIV-1 Env Protein

Current HIV research, 2018, Vol.16 (1), p.21-28

Moore, Penny L.

2018

Volltextzugriff (PDF)

The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection

Journal of Virology, 2011-05, Vol.85 (10), p.4828-4840

2011

Volltextzugriff (PDF)

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies

PLoS pathogens, 2022-09, Vol.18 (9), p.e1010450-e1010450

2022

Volltextzugriff (PDF)

Leveraging on past investment in understanding the immunology of COVID-19 - the South African experience

South African Journal of Science, 2022-05, Vol.118 (5-6), p.15-19

2022

Volltextzugriff (PDF)

Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape

Nature medicine, 2012-11, Vol.18 (11), p.1688-1692

2012

Volltextzugriff (PDF)

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies

PLoS pathogens, 2018-04, Vol.14 (4), p.e1006987-e1006987

2018

Volltextzugriff (PDF)

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages

Scientific reports, 2023-01, Vol.13 (1), p.1222-1222, Article 1222

2023

Volltextzugriff (PDF)

SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021

BMC medicine, 2021-11, Vol.19 (1), p.303-303, Article 303

2021

Volltextzugriff (PDF)

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection

PLoS pathogens, 2021-11, Vol.17 (11), p.e1010046-e1010046

2021

Volltextzugriff (PDF)

Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virions

Nature communications, 2018-10, Vol.9 (1), p.4489-14, Article 4489

2018

Volltextzugriff (PDF)

HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function

Frontiers in immunology, 2021-09, Vol.12, p.733958-733958

2021

Volltextzugriff (PDF)

Evaluating the antibody response elicited by diverse HIV envelope immunogens in the African green monkey (Vervet) model

Scientific reports, 2024-06, Vol.14 (1), p.13311-11

2024

Volltextzugriff (PDF)

The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256

PloS one, 2018-12, Vol.13 (12), p.e0208310-e0208310

2018

Volltextzugriff (PDF)

Triggering rare HIV antibodies by vaccination

Science (American Association for the Advancement of Science), 2022-12, Vol.378 (6623), p.949-950

Moore, Penny L.

2022

Volltextzugriff (PDF)

HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual

Journal of virology, 2016-12, Vol.90 (24), p.11132-11144

2016

Volltextzugriff (PDF)

Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals

Journal of Virology, 2011-11, Vol.85 (21), p.11502-11519

2011

Volltextzugriff (PDF)

Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection

Current opinion in HIV & AIDS, 2014-05, Vol.9 (3), p.210-216

2014

Volltextzugriff (PDF)

Building a Resilient Scientific Network for COVID-19 and Beyond

mBio, 2022-10, Vol.13 (5), p.e0222322-e0222322

2022

Volltextzugriff (PDF)

Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition

Cell reports (Cambridge), 2020-04, Vol.31 (1), p.107488-107488, Article 107488

2020

Volltextzugriff (PDF)

Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection

PLoS pathogens, 2009-09, Vol.5 (9), p.e1000598-e1000598

2009

Volltextzugriff (PDF)

Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms

Scientific reports, 2022-10, Vol.12 (1), p.16473-16473, Article 16473

2022

Volltextzugriff (PDF)

Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope

Journal of virology, 2017-09, Vol.91 (18)

2017

Volltextzugriff (PDF)

1 – 25 von 295

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(267)
Mit Volltextzugriff
(255)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(197)
Life Sciences & Biomedicine
(175)
Humans
(146)
Virology
(76)
Hiv
(66)
Female
(62)
Immunology
(62)
Hiv-1 - Immunology
(58)
Human Immunodeficiency Virus
(56)
Antibodies
(55)
Vaccines
(54)
Hiv Infections - Immunology
(51)
Microbiology
(44)
Infections
(43)
Antibodies, Neutralizing - Immunology
(42)
Hiv Antibodies - Immunology
(41)
Neutralization
(38)
Adult
(35)
Infectious Diseases
(35)
Male
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Virology
(29)
Physical Review Letters
(29)
Plos Pathogens
(23)
Frontiers In Immunology
(9)
Virology
(9)
Aids Research And Human Retroviruses
(7)
Current Opinion In Hiv & Aids
(6)
Nature
(6)
Cell Host & Microbe
(5)
Current Opinion In Hiv And Aids
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody

Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes

The Neutralizing Antibody Response to the HIV-1 Env Protein

The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies

Leveraging on past investment in understanding the immunology of COVID-19 - the South African experience

Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages

SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection

Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virions

HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function

Evaluating the antibody response elicited by diverse HIV envelope immunogens in the African green monkey (Vervet) model

The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256

Triggering rare HIV antibodies by vaccination

HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual

Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals

Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection

Building a Resilient Scientific Network for COVID-19 and Beyond

Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition

Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection

Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms

Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope

Suchergebnisse filtern